Tokio Marine Asset Management Co. Ltd. acquired a new position in MEDNAX Inc (NYSE:MD) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 30,900 shares of the company’s stock, valued at approximately $1,651,000.
A number of other institutional investors have also modified their holdings of MD. Dimensional Fund Advisors LP boosted its position in shares of MEDNAX by 13.2% during the second quarter. Dimensional Fund Advisors LP now owns 1,131,563 shares of the company’s stock worth $68,315,000 after buying an additional 132,315 shares during the period. QS Investors LLC boosted its position in shares of MEDNAX by 0.3% during the second quarter. QS Investors LLC now owns 3,812 shares of the company’s stock worth $230,000 after buying an additional 12 shares during the period. Shelton Capital Management purchased a new position in shares of MEDNAX during the second quarter worth $423,000. Nomura Holdings Inc. purchased a new position in shares of MEDNAX during the second quarter worth $347,000. Finally, BB&T Investment Services Inc. purchased a new position in shares of MEDNAX during the second quarter worth $243,000. Institutional investors own 98.67% of the company’s stock.
Several research analysts have recently commented on the company. Jefferies Group set a $50.00 price target on MEDNAX and gave the stock a “hold” rating in a research report on Tuesday. Mizuho set a $49.00 price target on MEDNAX and gave the stock a “hold” rating in a research report on Wednesday, January 24th. Stifel Nicolaus restated a “hold” rating and set a $56.00 price target on shares of MEDNAX in a research report on Wednesday, January 24th. Zacks Investment Research upgraded MEDNAX from a “hold” rating to a “buy” rating and set a $60.00 price target for the company in a research report on Tuesday, January 23rd. Finally, SunTrust Banks set a $55.00 price target on MEDNAX and gave the stock a “hold” rating in a research report on Thursday, December 21st. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the stock. MEDNAX currently has an average rating of “Hold” and an average price target of $54.75.
In other news, insider John C. Pepia sold 3,000 shares of the stock in a transaction on Tuesday, December 12th. The stock was sold at an average price of $51.58, for a total value of $154,740.00. Following the sale, the insider now directly owns 35,569 shares in the company, valued at $1,834,649.02. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 2.40% of the stock is currently owned by company insiders.
TRADEMARK VIOLATION NOTICE: “Tokio Marine Asset Management Co. Ltd. Acquires Shares of 30,900 MEDNAX Inc (MD)” was originally published by Community Financial News and is owned by of Community Financial News. If you are accessing this story on another website, it was illegally copied and republished in violation of United States and international copyright laws. The correct version of this story can be viewed at https://www.com-unik.info/2018/02/08/tokio-marine-asset-management-co-ltd-acquires-shares-of-30900-mednax-inc-md.html.
MEDNAX, Inc is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of December 31, 2016, the Company’s national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications.
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MEDNAX Inc (NYSE:MD).
Receive News & Ratings for MEDNAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDNAX and related companies with MarketBeat.com's FREE daily email newsletter.